27840085|t|Lowering the overall charge on TMPyP4 improves its selectivity for G-quadruplex DNA
27840085|a|Ligands that stabilize non-canonical DNA structures called G-quadruplexes (GQs) might have applications in medicine as anti-cancer agents, due to the involvement of GQ DNA in a variety of cancer-related biological processes. Five derivatives of 5,10,15,20-tetrakis(N-methyl-4-pyridyl)porphyrin (TMPyP4), where a N-methylpyridyl group was replaced with phenyl (4P3), 4-aminopheny l (PN3M), 4-phenylamidoproline (PL3M), or 4-carboxyphenyl (PC3M and P2C2M) were investigated for their interactions with human telomeric DNA (Tel22) using fluorescence resonance energy transfer (FRET) assay, and UV-visible and circular dichroism spectroscopies in K(+) buffer. The molecules are cationic or zwitterionic with an overall charge of 3+ (4P3, PN3M, and PL3M), 2+ (PC3M) or neutral (P2C2M). All porphyrins except P2C2M stabilize human telomeric DNA in FRET assays by ∼20 °C at 5 eq CD melting experiments suggest that 4P3 is the most stabilizing ligand with a stabilization temperature of 16.8 °C at 4 eq. Importantly, 4P3, PC3M and PL3M demonstrate excellent selectivity for quadruplexes, far superior to that of TMPyP4. Binding constants, determined using UV-vis titrations, correlate with charge: triply cationic 4P3, PN3M and PL3M display Ka of 5-9 μM(-1), doubly cationic PC3M displays Ka of 1 μM(-1), and neutral P2C2M displays weak-to-no binding. UV-vis data suggest that binding interactions are driven by electrostatic attractions and that the binding mode may be base-stacking (or end-stacking) judging by the high values of red shift (15-20 nm) and hypochromicity (40-50%). We conclude that lowering the charge on TMPyP4 to 3+ can achieve the desired balance between stabilizing ability, affinity, and high selectivity required for an excellent quadruplex ligand.
27840085	31	37	TMPyP4	T103	UMLS:C0076211
27840085	67	83	G-quadruplex DNA	T082	UMLS:C1956090
27840085	84	91	Ligands	T103	UMLS:C0023688
27840085	121	135	DNA structures	T103	UMLS:C1511699
27840085	143	157	G-quadruplexes	T082	UMLS:C1517336
27840085	159	162	GQs	T082	UMLS:C1517336
27840085	191	199	medicine	T103	UMLS:C0013227
27840085	203	221	anti-cancer agents	T103	UMLS:C0003392
27840085	249	255	GQ DNA	T082	UMLS:C1956090
27840085	272	286	cancer-related	T033	UMLS:C2826292
27840085	287	307	biological processes	T038	UMLS:C3714634
27840085	329	377	5,10,15,20-tetrakis(N-methyl-4-pyridyl)porphyrin	T103	UMLS:C0076211
27840085	379	385	TMPyP4	T103	UMLS:C0076211
27840085	444	447	4P3	T103	UMLS:C1254351
27840085	466	470	PN3M	T103	UMLS:C1254351
27840085	495	499	PL3M	T103	UMLS:C1254351
27840085	522	526	PC3M	T103	UMLS:C1254351
27840085	531	536	P2C2M	T103	UMLS:C1254351
27840085	566	578	interactions	T038	UMLS:C0687133
27840085	584	589	human	T204	UMLS:C0086418
27840085	590	603	telomeric DNA	T017	UMLS:C0085187
27840085	605	610	Tel22	T082	UMLS:C0314659
27840085	618	656	fluorescence resonance energy transfer	T058	UMLS:C0597717
27840085	658	662	FRET	T058	UMLS:C0597717
27840085	727	738	K(+) buffer	T103	UMLS:C0006353
27840085	758	766	cationic	T103	UMLS:C0007447
27840085	813	816	4P3	T103	UMLS:C1254351
27840085	818	822	PN3M	T103	UMLS:C1254351
27840085	828	832	PL3M	T103	UMLS:C1254351
27840085	839	843	PC3M	T103	UMLS:C1254351
27840085	857	862	P2C2M	T103	UMLS:C1254351
27840085	869	879	porphyrins	T103	UMLS:C0032712
27840085	887	892	P2C2M	T103	UMLS:C1254351
27840085	903	908	human	T204	UMLS:C0086418
27840085	909	922	telomeric DNA	T017	UMLS:C0085187
27840085	926	937	FRET assays	T058	UMLS:C0597717
27840085	956	978	CD melting experiments	T058	UMLS:C0022885
27840085	992	995	4P3	T103	UMLS:C1254351
27840085	1020	1026	ligand	T103	UMLS:C0023688
27840085	1093	1096	4P3	T103	UMLS:C1254351
27840085	1098	1102	PC3M	T103	UMLS:C1254351
27840085	1107	1111	PL3M	T103	UMLS:C1254351
27840085	1150	1162	quadruplexes	T082	UMLS:C1956090
27840085	1188	1194	TMPyP4	T103	UMLS:C0076211
27840085	1232	1249	UV-vis titrations	T058	UMLS:C0022885
27840085	1274	1293	triply cationic 4P3	T103	UMLS:C1254351
27840085	1295	1299	PN3M	T103	UMLS:C1254351
27840085	1304	1308	PL3M	T103	UMLS:C1254351
27840085	1335	1355	doubly cationic PC3M	T103	UMLS:C1254351
27840085	1393	1398	P2C2M	T103	UMLS:C1254351
27840085	1419	1426	binding	T038	UMLS:C1148673
27840085	1453	1473	binding interactions	T038	UMLS:C1148673
27840085	1527	1534	binding	T038	UMLS:C1148673
27840085	1699	1705	TMPyP4	T103	UMLS:C0076211
27840085	1830	1840	quadruplex	T082	UMLS:C1956090
27840085	1841	1847	ligand	T103	UMLS:C0023688